作者
Christina Jackson,Christopher Cherry,Sadhana Bom,Arbor G. Dykema,Rulin Wang,Elizabeth A. Thompson,Ming Zhang,Runzhe Li,Zhicheng Ji,Wenpin Hou,W. S. Zhan,Hao Zhang,John Choi,Ajay Vaghasia,Landon J. Hansen,William Lee Wang,Brandon Hwa-Lin Bergsneider,Kate M. Jones,Fausto J. Rodríguez,Jon Weingart,Calixto‐Hope G. Lucas,Jonathan D. Powell,Jennifer H. Elisseeff,Srinivasan Yegnasubramanian,Michael Lim,Chetan Bettegowda,Hongkai Ji,Drew M. Pardoll
摘要
The role of glioma-associated myeloid cells in tumor growth and immune evasion remains poorly understood. We performed single-cell RNA sequencing of immune and tumor cells from 33 gliomas, identifying two distinct myeloid-derived suppressor cell (MDSC) populations in isocitrate dehydrogenase–wild-type (IDT-WT) glioblastoma: an early progenitor MDSC (E-MDSC) population with up-regulation of metabolic and hypoxia pathways and a monocytic MDSC (M-MDSC) population. Spatial transcriptomics demonstrated that E-MDSCs geographically colocalize with metabolic stem-like tumor cells in the pseudopalisading region. Ligand-receptor analysis revealed cross-talk between these cells, where glioma stem-like cells produce chemokines attracting E-MDSCs, which in turn produce growth factors for the tumor cells. This interaction is absent in IDH-mutant gliomas, associated with hypermethylation and repressed gene expression of MDSC-attracting chemokines. Our study elucidates specific MDSCs that may facilitate glioblastoma progression and mediate tumor immunosuppression.